Acute Pancreatitis, Two Attacks with Normal Serum Amylase and Lipase - A Rare Case Report
Santo A Carnazzo1, Andrea Musumeci2, Rosalia Latino3, Paolo D Cannizzaro3
1Departement of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
2Radiodiagnostic and Radiotherapy Unit, University of Catania, Catania, Italy
3Department of General Surgery and Medical-Surgical Specialty, University of Catania, Catania, Italy
Received Date: May 25th, 2019; Accepted Date: June 27th, 2019
Context Acute pancreatitis is most commonly caused by gallstones or chronic alcohol use and accounts for more than 200,000 hospital admissions annually. Guidelines by the American College of Gastroenterology state that the diagnosis of acute pancreatitis requires the presence of two of the following three criteria: 1) abdominal pain consistent with the disease; 2) serum amylase and/or lipase greater than three times the upper limit of normal; 3) characteristic findings from abdominal imaging. Acute pancreatitis with normal serum amylase and/or lipase level in acute pancreatitis is an extremely rare occurrence.
Case report Herein we present a case report with imaging-proven acute pancreatitis with normal serum amylase and lipase levels.
Conclusion Acute pancreatitis is not always associated with increased levels of serum amylase and lipase and these markers can be misleading for the correct diagnosis.
Case Reports; Gallbladder; Pancreatitis
AP Acute pancreatitis; CECT Contrastenhanced computed tomography; ERCP Endoscopic retrograde cholangiopancreatography
Although most cases of Acute Pancreatitis (AP) are caused by gallstones. Less often, the disease is contracted for alcohol abuse, following Endoscopic Retrograde Cholangiopancreatography (ERCP), in the course of hypertriglyceridemia and other causes. Despite the improvement of diagnostic technologies the etiology of AP remains unclear in about 20% of patients and is defined as Idiopathic AP (IAP). In accordance with the Atlanta classification, acute pancreatitis can be diagnosed if at least 2 of the following 3 criteria are fulfilled: abdominal pain; serum lipase or/and amylase activity at least 3 times the upper limit of normal; or characteristic findings of acute pancreatitis on contrast-enhanced Computed Tomography (CT) [1, 2].
Amylase and lipase, secreted by the acinar cells of the pancreas, are the most common laboratory markers used to establish the diagnosis of acute pancreatitis: amylase levels remain within abnormal range in 80-95% of cases; serum lipase levels typically increase in 95-100% of cases [3, 4].
Acute pancreatitis in the setting of a normal serum amylase or lipase is uncommon, normal serum amylase and lipase in the setting of acute pancreatitis is an extremely rare occurrence [5, 6, 7, 8, 9, 10, 11].
Nevertheless, both lipase and amylase alone lack the ability to determine the severity and etiology of acute pancreatitis; the reason for the variability of serum increases during AP is also uncertain . Contrast- Enhanced Computed Tomography (CECT) is useful for the diagnosis of local complications with acute pancreatitis but its role as a prognostic tool remains controversial. Magnetic resonance imaging and Endoscopic Ultrasonography (EUS) should be reserved for patients in whom the diagnosis is unclear [1, 2].
A Fifty-five-year-old Caucasian female was admitted to the Emergency Department complaining nausea, vomiting, severe acute abdominal pain and distension. Her past medical history is significant for hypertension and hepatitis B. There was no documented history of hypertriglyceridemia. She was not an alchoholic. Her main laboratory results were: white blood cell count 8 200×109 (N 3 500–11 500 109/L); glycemia 154 (N 70- 99 mg/dL); total bilirubin 0.7 (N 0.3-1.2 mg/dL); GGT 14 (N<38 U/L); alanine aminotransferase 39 (N<35 U/l); serum amylase 64 (N 28-100 U/L); serum lipase 21 (N 0-67 U/L); lactate dehydrogenase 257 (N 0-248 mmol/L); C-reactive protein 3.2 (N 0-5 mg/dL); creatinine 0.47 (N 0.51-0.95 mg/ dL). Chest X-Ray and electrocardiograph were negative.
The patient was discharged home with a diagnosis of gastroenteritis. After 24 hours the patient was admitted again to the Emergency Department with persistent and severe acute abdominal pain and distension.
Her main laboratory results were: white blood cell count 13,880×109; glycemia 182; total bilirubin 1.2; GGT 14; alanine aminotransferase 21; serum amylase 46; serum lipase 18; lactate dehydrogenase 465; C-reactive protein 5.5; creatinine 0.54.
Patient was admitted and was started on intravenous fluids and broad-spectrum antibiotics. On day three of hospitalization, patient developed worsening abdominal pain and distension, with blood pressure of 95/55 mmHg, with a heart rate of 95/min; the oxygen saturation was 78% on room air.
A CECT was performed and showed extensive pancreatic edema, especially involving the pancreatic head, and peripancreatic stranding; peripancreatic fluid collection are present, around the spleen, in the space of Morrison and in posterior cul-de-sac of Douglas (Figure 1).
Upon arrival to the department, the patient was mild responsive, tachypneic and hypotensive with a blood pressure of 90/55 mmHg, heart rate of 105/min; the oxygen saturation was 68% on room air, oliguria, severe abdominal pain.
Her main laboratory results were: white blood cell counts 7,200×109; glycemia 182; total bilirubin 1.1; GGT 14; alanine aminotransferase 21; serum amylase 52; serum lipase 18; lactate dehydrogenase 284; C-reactive protein 5.5; creatinine 0.59.
She underwent Magnetic Resonance (MR) imaging of abdomen that revealed normal findings of gall bladder, biliary tract, and common bile duct without gallstones and peripancreatic fluid collections (Figure 2).
Based on clinical presentation, laboratory results and radiological findings, the diagnosis of Severe Acute Pancreatitis (SAP) was made, like revised Atlanta classification . The patient started on aggressive intravenous fluid hydration, pain management with diclofenac iv, intravenous meropenem, pantoprazole 40 mg iv, low flow O2 therapy and bowel rest.
The patient had a good improvement in symptoms after 48 hours. On day six of hospitalization in our department, patient started oral nutrition and developed abdominal pain, associated with nausea and vomiting.
Notable values were: white blood cell counts 6 500×109; total bilirubin 1.6; GGT 75; alanine aminotransferase 107; serum amylase 51; serum lipase 50; lactate dehydrogenase 345; C-reactive protein 106; creatinine 0.46.
A repeat CT abdomen was done on day 6 due to persistent abdominal pain and it revealed worsening evidence of inflammation, normal findings of gallbladder, common bile duct was of normal diameter and intrabiliary duct dilatation was noted (Figure 3). She was treated with the same therapy at admission in our department.
On day nine of hospitalization patient had a good improvement in symptoms and EUS showed sludge of gallbladder. Patient was able to tolerate a regular diet and noted an almost complete resolution of pain, and therefore was discharged home and a few months later she underwent surgery for cholecystectomy without any complications. Six months after cholecystectomy the patient no longer had similar symptoms.
Acute pancreatitis is a common disorder. Serum lipase level increases in 3 to 6 hours, peaks in 24 hours and remains elevated for one to two weeks. Nevertheless, few studies have suggested that serum lipase is a more sensitive biomarker of acute pancreatitis compared to serum amylase and several studies have reported a negative predictive value of serum lipase in diagnosing acute pancreatitis to be between 94 and 100 percent. However, serum amylase levels may remain within normal range in 20% of patients admitted with acute pancreatitis, serum lipase levels may remain within normal range only in 5% of patients with the same diagnosis .
This is an extremely rare case of acute pancreatitis with normal amylase and lipase levels. Our patient was admitted with a clinical picture consistent with acute pancreatitis despite normal lipase and amylase levels (Figures 4, 5, 6), condition that can be critical in the timely diagnosis and management of these patient.
In our case, patient’s lipase and amylase levels were within normal limits at admission and subsequent days with consequent delay in the diagnosis of AP and its treatment. Morbidity and mortality in AP are driven by early or late POF, following a delay in the diagnosis.
The patient had two attacks of AP and the lipase and amylase levels were within normal limits during both attacks.
The patient’s access to our emergency department during the painful attack excludes that the missed increase in amylase and lipase is related to a laboratory evaluation delay. The non-use of alcohol related to the hepatitis B disease also excludes the possibility that the missed increase is linked to this habit of life. In our case report the lack of increase in amylase and lipase is repeated even during the second attack. The risk to visit a patient with SAP without increasing amylases and lipases is a delayed diagnosis or a serious unrecognized inflammatory disease with possible complications . EUS should be performed in all patients whom the diagnosis of pancreatitis remains idiopathic if CECT and MRCP are negative .
In conclusions, serum amylase and lipase levels help in diagnosis making of most AP cases due to their simplicity and relative ease in measurement. Acute pancreatitis with normal serum amylase and lipase is a rare phenomenon which can occur. AP is not always associated with increased levels of serum amylase and lipase. If the clinical diagnosis is strongly suspected further imaging modalities may be helpful and CECT should be performed without delay.
The authors disclose no financial relationships or conflict of interest relevant to this publication.